Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neurosci Biobehav Rev ; 66: 54-60, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27126289

ABSTRACT

Recent research has begun to elucidate the neural basis of higher order social concepts, such as the mechanisms involved in intergroup relations, and moral judgments. Most theories have concentrated on higher order emotions, such as guilt, shame, or empathy, as core mechanisms. Accordingly, psychopharmacological and neurobiological studies have investigated the effects of manipulating serotonin or oxytocin activity on moral and social decisions and attitudes. However, recently it has been determined that changes in more basic emotions, such as fear and anger, might also have a significant role in social and moral cognition. This article summarizes psychopharmacological and fMRI research on the role of noradrenaline in higher order social cognition suggesting that indeed noradrenergic mediated affective changes might play key - and probably causal - role in certain social attitudes and moral judgments. Social judgments may also be directly influenced by numerous neurotransmitter manipulations but these effects could be mediated by modulation of basic emotions which appear to play an essential role in the formation of social concepts and moral behaviour.


Subject(s)
Morals , Social Behavior , Emotions , Humans , Interpersonal Relations , Norepinephrine
2.
Psychopharmacology (Berl) ; 232(16): 2951-8, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25899791

ABSTRACT

INTRODUCTION: The beta-adrenoceptor antagonist propranolol is known to reduce peripheral and central activity of noradrenaline. A recent study found that intervention with propranolol diminished negative implicit racial bias. MATERIALS AND METHOD: The current study used functional magnetic resonance imaging (fMRI) in order to determine the neural correlates of this effect. Healthy volunteers (N = 40) of white ethnic origin received a single oral dose (40 mg) of propranolol, in a randomised, double-blind, parallel group, placebo-controlled design, before viewing unfamiliar faces of same and other race. RESULTS AND DISCUSSION: We found significantly reduced activity in the fusiform gyrus and thalamus following propranolol to out-group faces only. Additionally, propranolol lowered the implicit attitude score, without affecting explicit prejudice measure. CONCLUSION: These findings suggest that noradrenaline pathways might modulate racial bias by acting on the processing of categorisation in the fusiform gyrus.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Face , Prejudice , Propranolol/pharmacology , Temporal Lobe/drug effects , Black or African American , Attitude , Double-Blind Method , Female , Humans , Magnetic Resonance Imaging , Male , Photic Stimulation , Temporal Lobe/physiology , White People , Young Adult
3.
Psychopathology ; 27(6): 273-80, 1994.
Article in English | MEDLINE | ID: mdl-7846250

ABSTRACT

A patient may experience hallucinations in more than one modality simultaneously or at different times and they may or may not appear to emanate from a single source. Current nomenclature is imprecise, often has particular diagnostic implications and fails to distinguish between these different phenomena. This has resulted in considerable confusion with a tendency to dismiss the importance of these symptoms. The various terms in current usage and the presence of these symptoms in a variety of different conditions are examined. To aid further research and improve clinical practice the authors advocate the use of the term multi-modal hallucinations and suggest operational criteria.


Subject(s)
Hallucinations/classification , Mental Disorders/classification , Auditory Perception , Hallucinations/diagnosis , Hallucinations/psychology , Humans , Mental Disorders/diagnosis , Mental Disorders/psychology , Neurocognitive Disorders/classification , Neurocognitive Disorders/diagnosis , Neurocognitive Disorders/psychology , Psychotic Disorders/classification , Psychotic Disorders/diagnosis , Psychotic Disorders/psychology , Touch , Visual Perception
4.
Lancet ; 2(8671): 1067-9, 1989 Nov 04.
Article in English | MEDLINE | ID: mdl-2572797

ABSTRACT

A randomised, double-blind, placebo-controlled study of L-tyrosine was done in ten subjects with narcolepsy and cataplexy. Of twenty-eight visual analogue scales rating mood and arousal, the subjects' ratings in the tyrosine treatment (9 g daily) and placebo periods differed significantly for only three (less tired, less drowsy, more alert). Ratings of daytime drowsiness, cataplexy, sleep paralysis, night-time sleep, overall clinical response, and measurements of multiple sleep latency and tests of speed and attention did not differ significantly between tyrosine and placebo periods. Dietary supplementation with tyrosine 9 g daily for 4 weeks seems to have a mild stimulant action on the central nervous system but this effect is not clinically significant in the treatment of the narcoleptic syndrome.


Subject(s)
Narcolepsy/drug therapy , Tyrosine/therapeutic use , Adult , Affect/drug effects , Arousal/drug effects , Behavior/drug effects , Cataplexy/drug therapy , Double-Blind Method , Drug Evaluation , Female , Humans , Male , Middle Aged , Random Allocation , Sleep, REM/drug effects , Tyrosine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...